Literature DB >> 23402993

Spiral drawing during self-rated dyskinesia is more impaired than during self-rated Off.

Mevludin Memedi1, Jerker Westin, Dag Nyholm.   

Abstract

OBJECTIVE: The purpose of this study was to examine repeated measures of fine motor function in relation to self-assessed motor conditions in Parkinson's disease (PD).
METHODS: One-hundred PD patients, 65 with advanced PD and 35 patients with different disease stages have utilized a test battery in a telemedicine setting. On each test occasion, they initially self-assessed their motor condition (from 'very off' to 'very dyskinetic') and then performed a set of fine motor tests (tapping and spiral drawings).
RESULTS: The motor tests scores were found to be the best during self-rated On. Self-rated dyskinesias caused more impaired spiral drawing performance (mean = 9.8% worse, P < 0.001) but at the same time tapping speed was faster (mean = 5.0% increase, P < 0.001), compared to scores in self-rated Off.
CONCLUSIONS: The fine motor tests of the test battery capture different symptoms; the spiral impairment primarily relates to dyskinesias whereas the tapping speed captures the Off symptoms.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23402993     DOI: 10.1016/j.parkreldis.2013.01.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  2 in total

1.  Automatic and objective assessment of alternating tapping performance in Parkinson's disease.

Authors:  Mevludin Memedi; Taha Khan; Peter Grenholm; Dag Nyholm; Jerker Westin
Journal:  Sensors (Basel)       Date:  2013-12-09       Impact factor: 3.576

2.  Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease.

Authors:  Mevludin Memedi; Aleksander Sadikov; Vida Groznik; Jure Žabkar; Martin Možina; Filip Bergquist; Anders Johansson; Dietrich Haubenberger; Dag Nyholm
Journal:  Sensors (Basel)       Date:  2015-09-17       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.